David M. Arana

1.4k total citations
30 papers, 1.0k citations indexed

About

David M. Arana is a scholar working on Epidemiology, Infectious Diseases and Molecular Medicine. According to data from OpenAlex, David M. Arana has authored 30 papers receiving a total of 1.0k indexed citations (citations by other indexed papers that have themselves been cited), including 20 papers in Epidemiology, 14 papers in Infectious Diseases and 10 papers in Molecular Medicine. Recurrent topics in David M. Arana's work include Antifungal resistance and susceptibility (10 papers), Antibiotic Resistance in Bacteria (10 papers) and Fungal Infections and Studies (9 papers). David M. Arana is often cited by papers focused on Antifungal resistance and susceptibility (10 papers), Antibiotic Resistance in Bacteria (10 papers) and Fungal Infections and Studies (9 papers). David M. Arana collaborates with scholars based in Spain, France and United States. David M. Arana's co-authors include Jesús Plá, Rebeca Alonso‐Monge, César Nombela, Elvira Román, Juan-Ignacio Alós, Margarita Rubio Alonso, Blanca Eisman, Richard Calderone, Chen Du and Daniel Prieto and has published in prestigious journals such as The Journal of Experimental Medicine, Scientific Reports and Infection and Immunity.

In The Last Decade

David M. Arana

29 papers receiving 1.0k citations

Peers

Countries citing papers authored by David M. Arana

Since Specialization

Citations

This map shows the geographic impact of David M. Arana's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by David M. Arana with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites David M. Arana more than expected).

Fields of papers citing papers by David M. Arana

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by David M. Arana. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by David M. Arana. The network helps show where David M. Arana may publish in the future.

Co-authorship network of co-authors of David M. Arana

This figure shows the co-authorship network connecting the top 25 collaborators of David M. Arana. A scholar is included among the top collaborators of David M. Arana based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with David M. Arana. David M. Arana is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Emergence of NDM-1- and OXA-23-Co-Producing Acinetobacter baumannii ST1 Isolates from a Burn Unit in Spain 2025 ·Microorganisms ·Elena Hidalgo, (unknown), Marı́a Pérez-Vázquez, (unknown), J. Cañada, (unknown), Belén Aracil, David M. Arana, Jesús Oteo	2
2	Impact of the COVID-19 Pandemic on Pediatric Bacterial Community–acquired Pneumonia: A Multicenter Retrospective Study in Madrid, Spain 2024 ·The Pediatric Infectious Disease Journal ·David Aguilera‐Alonso, (unknown), (unknown), Teresa del Rosal, Francisco José Sanz-Santaeufemia, Beatriz Soto, Jesús Saavedra‐Lozano, Luis Prieto, (unknown), (unknown), Emilia Cercenado, Mercedes Marı́n, (unknown), Emilio Cendejas‐Bueno, (unknown), David M. Arana, José Yuste, Fernando Baquero‐Artigao, Cristina Calvo	0
3	A simple double differential centrifugation-wash procedure to rapidly obtain bacterial identification and direct antimicrobial susceptibility testing from positive blood cultures 2023 ·Enfermedades infecciosas y microbiologia clinica (English ed ) ·David M. Arana, (unknown), (unknown)	1
4	Evaluation of the Chagas VirClia® and Chagas TESA VirClia® for the Diagnosis of Trypanosoma cruzi Infection 2022 ·Pathogens ·(unknown), David M. Arana, (unknown), (unknown), (unknown), Javier Nieto, María Flóres-Chávez	4
5	A Prospective Study of the Serological, Clinical, and Epidemiological Features of a SARS-CoV-2 Positive Pediatric Cohort 2022 ·Children ·(unknown), (unknown), Arantxa Berzosa, Marta Illán Ramos, (unknown), (unknown), (unknown), (unknown), (unknown), David M. Arana, Juan-Ignacio Alós, (unknown), Alberto Delgado‐Iribarren, Manuel Fuentes, (unknown)	2
6	Identification of Clinical Isolates of Candida albicans with Increased Fitness in Colonization of the Murine Gut 2021 ·Journal of Fungi ·Rebeca Alonso‐Monge, Daniel Prieto, (unknown), (unknown), David M. Arana, (unknown), Elvira Román, Jesús Plá	6
7	ESBL-producing-multidrug resistant E. coli population from urinary tract infections is less diverse than non-ESBL-multidrug resistant population 2019 ·Enfermedades Infecciosas y Microbiología Clínica ·David M. Arana, (unknown), Verónica Bautista, Jesús Oteo, Juan-Ignacio Alós	3
8	Evolución de la multirresistencia a los antibióticos en Escherichia coli y Klebsiella pneumoniae aislados de infecciones del tracto urinario. Un análisis de 12 años (2003-2014) 2017 ·Enfermedades Infecciosas y Microbiología Clínica ·David M. Arana, Margarita Rubio Alonso, (unknown)	14
9	Characterization of mobile genetic elements carrying VIM-1 and KPC-2 carbapenemases in Citrobacter freundii isolates in Madrid 2017 ·International Journal of Medical Microbiology ·Jennifer Villa, David M. Arana, Esther Viedma, Dafne Pérez-Montarelo, Fernando Cháves	18
10	Evolution of antibiotic multiresistance in Escherichia coli and Klebsiella pneumoniae isolates from urinary tract infections: A 12-year analysis (2003–2014) 2016 ·Enfermedades Infecciosas y Microbiología Clínica ·David M. Arana, Margarita Rubio Alonso, Juan-Ignacio Alós	32
11	Primer aislado clínico de Streptococcus grupo B con resistencia a clindamicina mediada por el gen lnu(B) en Europa 2014 ·Revista española de quimioterapia. Suplemento ·David M. Arana, Beatriz Rojo‐Bezares, (unknown), Juan-Ignacio Alós	14
12	Sensibilidad a azitromicina y otros antibióticos en aislados recientes de Salmonella, Shigella y Yersinia 2014 ·Enfermedades Infecciosas y Microbiología Clínica ·(unknown), David M. Arana, (unknown), Juan-Ignacio Alós	6
13	Concurrent interspecies and clonal dissemination of OXA-48 carbapenemase 2014 ·Clinical Microbiology and Infection ·David M. Arana, David Saéz, P. García-Hierro, V. Bautista, Sara Fernández-Romero, Miguel A. de la Cal, Juan-Ignacio Alós, Jesús Oteo	34
14	Betalactamasas de espectro extendido en las infecciones del tracto urinario causadas por enterobacterias: aproximación a su conocimiento y pautas de actuación 2014 ·Actas Urológicas Españolas ·A. García-Tello, H. Gimbernat, C. Redondo, David M. Arana, J. Cacho, J.C. Angulo	11
15	The Sko1 protein represses the yeast-to-hypha transition and regulates the oxidative stress response in Candida albicans 2010 ·Fungal Genetics and Biology ·Rebeca Alonso‐Monge, Elvira Román, David M. Arana, Daniel Prieto, (unknown), César Nombela, Jesús Plá	47
16	Fungi sensing environmental stress 2009 ·Clinical Microbiology and Infection ·Rebeca Alonso‐Monge, Elvira Román, David M. Arana, Jesús Plá, César Nombela	45
17	Fluconazole at subinhibitory concentrations induces the oxidative- and nitrosative-responsive genes TRR1, GRE2 and YHB1, and enhances the resistance of Candida albicans to phagocytes 2009 ·Journal of Antimicrobial Chemotherapy ·David M. Arana, César Nombela, Jesús Plá	30
18	The role of the cell wall in fungal pathogenesis 2008 ·Microbial Biotechnology ·David M. Arana, Daniel Prieto, Elvira Román, César Nombela, Rebeca Alonso‐Monge, Jesús Plá	57
19	Differential susceptibility of mitogen-activated protein kinase pathway mutants to oxidative-mediated killing by phagocytes in the fungal pathogen Candida albicans 2007 ·Cellular Microbiology ·David M. Arana, Rebeca Alonso‐Monge, Chen Du, Richard Calderone, Jesús Plá	95
20	MAP kinase pathways as regulators of fungal virulence 2007 ·Trends in Microbiology ·Elvira Román, David M. Arana, César Nombela, Rebeca Alonso‐Monge, Jesús Plá	125

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact